ClinVar Miner

Submissions for variant NM_000329.3(RPE65):c.762G>T (p.Glu254Asp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen RCV004801983 SCV005423714 likely pathogenic RPE65-related recessive retinopathy 2024-12-12 reviewed by expert panel curation The NM_000329.3(RPE65):c.762G>T (p.Glu254Asp) variant is a missense variant in RPE65 causing a substitution of glutamic acid with aspartic acid at position 254. This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.774, which is above the ClinGen LCA/eoRD VCEP threshold of ≥0.773 and predicts a damaging effect on RPE65 function (PP3_Moderate). This variant has been reported in at least 3 unrelated probands with early-onset severe retinal dystrophy who were homozygous for the variant (1 point, PM3, PMID: 35129589). At least one proband harboring this variant exhibits a phenotype including clinical diagnosis of LCA (0.5 pt) and significant, documented improvement of FST or other measure of dark-adapted vision after treatment with Luxturna or other RPE65 gene therapy. (8.5 points, PMID: 38295874, PP4_Moderate). In summary, this variant meets the criteria to be classified as Likely Pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: PM2_Supporting, PP3_Moderate, PP4_Moderate, PM3 (VCEP specifications version 1.0.0; date of approval 09/21/2023).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.